Login prior to clicking the links below

Keynote Lecture: The Evolution of Immunotherapy: Past, Present and Future Hans Hammers VIEW
Science Roundtable: Patient Derived Xenografts of Metastatic Renal Cell Carcinoma to Guide Dose Escalation Regiments and Drug Matching Matthew Lowerison VIEW
Science Roundtable: Baseline Edmonton Symptom Assessment Scale (ESAS) and Survival in Metastatic Renal Cell Carcinoma (mRCC) Jeffrey Graham VIEW
Science Roundtable: Genetic Testing for Hereditary Renal Cancer in Ontario: A Preliminary Retrospective Review Melanie Care VIEW
Science Roundtable: Y-box binding protein 1 is crucial in acquiring drug resistance in advanced renal cell carcinoma Ninadh D’Costa VIEW
Keynote Lecture: Radical Nephrectomy for Select Masses Amenable to Nephron Sparing Surgery: Therapeutic Heresy or Voice of Reason? Alexander Kutikov VIEW
Introduction: Future of Canadian kidney cancer surgical trials Michael Jewett VIEW
Renal Hypothermia Update Ilias Cagiannos VIEW
Discussion: Future of Canadian kidney cancer surgical trials Michael Jewett, Ricardo Rendon, Alan So, Ilias Cagiannos VIEW
Blind fight or are we any closer to develop predictive biomarkers for response Sumanta Pal VIEW
Oligometastatic Debate: Role of SBRT vs. Role of Surgery Patrick Cheung, Wes Kassouf VIEW
Keynote Lecture: Immunotherapy – ongoing trials / combination therapy Hans Hammers VIEW
Discussion: Canadian clinical trials discussion (I/O+ combo): What to prioritize? Anil Kapoor, Georg Bjarnason VIEW
National kidney cancer patient and caregiver survey Jennifer Jones, Heather Chappell VIEW
Keynote Lecture: Non clear cell – where are we now? Sumanta Pal VIEW
Germ line mutations Raymond Kim VIEW
Genomics in RCC – cfDNA and tumor DNA sequencing Alex Wyatt VIEW
Update Dragon’s Den project: Integrative Sequencing In Germline and Hereditary Tumours (INSIGHT) in non-clear cell RCC Raymond Kim VIEW
Keynote Lecture: Adjuvant Treatment – A new standard of care and implications on subsequent therapies? Thomas Powles VIEW
Chromosomal instability in cell-free DNA as plasma biomarkers for renal cell carcinoma George Yousef VIEW

Exploiting novel therapeutic targets to block metastasis of clear cell renal cell carcinoma

Jan K Rudzinski


Predictive Radiomics Signature for treatment response to nivolumab or PD-1/PD-L1 inhibitors in patients with advanced renal cell carcinoma

Hao-Wen Sim VIEW

Project Title: Identification of Predictive Biomarkers In Patients With Metastatic Kidney Cancer Using Circulating Tumor DNA Sequencing

Lucia Nappi VIEW
A Novel Immunotherapeutic Bi-specific T-cell Engager (BiTE) Strategy for RCC Keith Lawson VIEW
Update Dragon’s Den project: small renal mass biopsy Tony Finelli VIEW
Keynote Lecture: Surgery of Localized Kidney Cancer: Is a Chance to Cut a Chance to Cure? Alexander Kutikov VIEW
Keynote Lecture: The Changing Landscape of mRCC Thomas Powles VIEW
Banquet Dinner Highlights from a distinguished Canadian Oncologist's Career Peter Venner VIEW